Patent · US Active

Biological materials related to c-Met

US9346884B2 · kind B2 · utility

8Cited by

3References

5Claims

0Family size

Assignee

Ablynx N.V. · BE

Inventors

Gerald Beste · Evergem, BE
Guy Hermans · Merelbeke, BE
Soren Steffensen · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE
Alexander Szyroki · Goldenstedt, DE
Cedric Jozef Neotere Ververken · Merelbeke, BE
Tinneke Denayer · Zevergem, BE

Key dates

Filing date	Oct 1, 2012
Grant date	May 24, 2016
Priority date	—
Expiry date	Oct 1, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to biological materials related to c-Met possibly in combination with VEGF and/or EGFR, and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. Methods and kits for assessing the responsiveness of a patient to c-Met therapy are also described and provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.